Skip to content

Prevalence of Heavy Menstrual Bleeding in Female Population Living in Beijing

Prevalence of Heavy Menstrual Bleeding in Female Population Living in Beijing

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02304510
Enrollment
2455
Registered
2014-12-02
Start date
2014-11-30
Completion date
2016-12-31
Last updated
2018-12-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Menorrhagia

Keywords

Prevalence, Menorrhagia

Brief summary

The purpose of the study is to estimate the prevalence of heavy menstrual bleeding (HMB) in females aged between 18 and 50 years old living in Bejing.

Detailed description

This study is an observational, cross-sectional study. A representative sample of 2800 eligible women with different occupations such as farmers, service providers, workers, professional specialists, students and civil servants will be recruited. A cluster sampling method with probability proportional to the distribution of occupation in women in Beijing will be used. Demographic data will be collected by questionnaire. Menstrual bleeding will be evaluated by Pictorial Blood loss Assessment Chart (PBAC). According to the international definition of HMB, a PBAC score more than 100 is considered as HMB.

Interventions

None listed

Sponsors

Bayer
CollaboratorINDUSTRY
Peking University
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 50 Years
Healthy volunteers
No

Inclusion criteria

* Females aged between 18 and 50 years (inclusive) * Stay in Beijing for more than 6 months * Signed ICF was obtained

Exclusion criteria

* Not achieve the menarche * With the last menstruation more than one year ago * Experienced amenorrhea, currently take hormone therapy to induce menstruation * Had undergone a hysterectomy * Currently breastfeeding a baby * Being pregnant

Design outcomes

Primary

MeasureTime frame
Prevalence of HMBfrom date of inclusion until the end of the study currently planned (about 7 months)

Secondary

MeasureTime frameDescription
Prevalence of HMB in different subgroupsfrom date of inclusion until the end of the study currently planned (about 7 months)Subgroups include groups with different age, occupations, education levels, fertility status, with/without combined gynecological diseases.
Identify risk factors associated with HMBfrom date of inclusion until the end of the study currently planned (about 7 months)Identified HMB subjects will be assigned into the case group. Non-HMB subjects will be assigned into the control group. Logistic regression model will be carried out to analyze the associations between possible demographic factors and risk of HMB by calculating odds ratios (OR) with 95% confidence intervals (CIs).

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026